The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
AVBP
Health fund crosses 5% in ArriVent on day of stock collapse
Vivo Capital increased its holdings in pharmaceutical company ArriVent exactly on the day the stock plunged 47% after a clinical trial failure.
Other Stories
Alumis: director buys $10 million after a plunge
PremiumInsidersALMS1d ago2 min read
Super unusual activity in a small and dangerous company!
PremiumInsidersTENX2d ago2 min read
Special report: what's happening behind the scenes in the market?
Market Overview2h ago1 min read